🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆
Clinical Trials in Taiwan / NCT06914323
Active, not recruiting Not applicable

The Effects of Acupressure on Pain, Swelling and Comfort in Patients With Femoral Fracture Surgery

NCT06914323 · tracked via the Priya Life Science Taiwan tracker
Sponsor
Hungkuang University
Phase
Not applicable
Started
2025-02-18
Last updated
2025-04-06

Condition(s) studied

Acupressure

Investigational drug(s) / intervention(s)

Acupressure

Acupressure: improvements in pain, limb swelling, and comfort

Study summary

Pain is a subjective and unpleasant sensory and emotional experience associated with actual or potential tissue damage. Fractures result from a disruption in the continuity of bone, where bones are subjected to traction, twisting, or compression, causing damage to the surrounding muscular tissues. The treatment of displaced or complex fractures typically requires internal fixation surgery. 89% of fracture patients experience postoperative pain and swelling by the second day following open reduction and internal fixation surgery. These negative sensations can lead to increased pain, limb deformity, and neurovascular compression injuries. If postoperative pain is not adequately managed, it can affect wound healing, increase metabolism and oxygen consumption, and place additional strain on cardiopulmonary function. It is necessary to integrate alternative, non-pharmacological, non-invasive pain relief measures. Effectively and safely alleviating acute postoperative pain can enhance comfort, promote early mobilization, improve adherence to postoperative physical therapy, enhance quality of life and shorten hospital stays.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. The patient was hospitalized due to injuries from an accident, diagnosed with unilateral femoral fracture and underwent open reduction internal fixation surgery, hemiarthroplasty, and total hip arthroplasty. 2. Adults aged 18 years or older. 3. Conscious and able to communicate in Mandarin or Taiwanese (Min Nan). 4. Intact and without missing lower limbs. 5. Willing to sign the informed consent form after being briefed on the study objectives and procedures. Exclusion Criteria: 1. Diagnosis of musculoskeletal tumors. 2. History of cerebrovascular accident or peripheral vascular neuropathy. 3. Major medical conditions such as cirrhosis, renal failure, heart failure, cancer, and severe brain diseases. 4. Edema caused by nutritional deficiency or mucinous causes. 5. Pregnant or lactating women. 6. Patients using patient-controlled analgesia post-surgery. 7. Severe psychiatric disorders or perceptual disorders. 8. Platelet count less than 20 x 10\^3/uL before screening. 9. Albumin less than 3.5g/dL before screening. 10. Individuals closely related to the trial personnel, such as immediate family or dependents of the principal investigator.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hungkuang University Taichung Taiwan

More Hungkuang University trials in Taiwan

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06914323 on ClinicalTrials.gov ↗ ← All trials in Taiwan